Suzanne Louise Bruhn's Net Worth
$1.34 Million
Who is Suzanne Louise Bruhn?
Suzanne Louise Bruhn has an estimated net worth of $1.34 Million. This is based on reported shares across multiple companies, which include Travere Therapeutics, Inc., PLIANT THERAPEUTICS, INC., Aeglea BioTherapeutics, Inc., NOVELION THERAPEUTICS INC., Cerecor Inc., Mind Medicine (MindMed) Inc., Vigil Neuroscience, Inc., and Raptor Pharmaceutical Corp.
SEC CIK
Suzanne Louise Bruhn's CIK is 0001517790
Past Insider Trading and Trends
2024 was Suzanne Louise Bruhn's most active year for acquiring shares with 9 total transactions. Suzanne Louise Bruhn's most active month to acquire stocks was the month of May. 2013 was Suzanne Louise Bruhn's most active year for disposing of shares, totalling 9 transactions. Suzanne Louise Bruhn's most active month to dispose stocks was the month of August. 2015 saw Suzanne Louise Bruhn paying a total of $326,700.00 for 122,023 shares, this is the most they've acquired in one year. In 2016 Suzanne Louise Bruhn cashed out on 177,447 shares for a total of $510,903.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Travere Therapeutics, Inc. (TVTX) Snapshot price: $10.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +41.27% | 6.5K |
—
|
—
| 22.25K |
May 8
| |||
Form 4
| +40.00% | 4.5K |
—
|
—
| 15.75K |
May 17
| |||
Form 4
| +36.36% | 3K |
—
|
—
| 11.25K |
May 11
| |||
Form 4
| +57.14% | 3K |
—
|
—
| 8.25K |
May 14
| |||
Form 4
|
∞
| 5.25K |
—
|
—
| 5.25K |
Apr 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PLIANT THERAPEUTICS, INC. (PLRX) Snapshot price: $12.87
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aeglea BioTherapeutics, Inc. (AGLE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NOVELION THERAPEUTICS INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cerecor Inc. (AVTX) Snapshot price: $7.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||